drugset / Trial / NCT04677868
MTX and Steroid for aGVHD Treatment
NaSingle-groupOpen-labelTreatment
Summary
The aim of the study is to identify the efficacy and safety of methotrexate (MTX) combined corticosteroid treatment for acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Timeline
- Start
- 2020-12-23
- Primary completion
- 2021-06-01
- Completion
- 2022-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 10 mg | — |